Public Companies

Right before the stock market closed for the day, DuPont announced that it would split into three companies. CEO Ed Breen also announced that he would be stepping down as of June 1.

Artesian Resources has already spent $3.9 million on upgrading equipment at 10 facilities to treat for PFAS, also known as "forever chemicals."

One month after placing executives on leave, Chemours has updated its financials. The company is also fielding information requests from prosecutors and regulators.

Chemours has tapped Denise Dignam as its next leader, within a month of placing President and CEO Mark Newman and other financial executives on leave.

Chemours’ internal audit has found that three executives, including CEO Mark Newman, violated the company’s ethics code to alter the appearance of cash flow targets dating back to the end of 2022.

Padraig McDonnell has been named as the next CEO of Agilent, as its current leader Mike McMullen prepares to retire.

Looking into weaknesses in internal controls on financial reporting, Chemours has placed top leaders on administrative leave.

Navient's portfolio of student loans has shrunk over the decade, in part due to settlements and offloading federal loan services to other firms.

Prelude Therapeutics, a cancer drug development firm, closed a $25 million share sale Wednesday that will help extend its funding runway.

Edgar "Ed" S. Woolard Jr., the former CEO and chair of DuPont and chair of Apple who led the companies through tremendous change, died Monday.